Recursion Pharmaceuticals, Inc. (RXRX): Shares Outstanding

Annual figures by period end, from SEC filings.

528.18M
As of 2025-12-31
534.12M
As of 2026-06-30
+40.4%
3-year compound annual growth
+88.3%
5-year compound annual growth
2020-12-31: 22.31M2021-12-31: 170.27M2022-12-31: 191.02M2023-12-31: 234.27M2024-12-31: 396.80M2025-12-31: 528.18M528.18M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31528.18M+33.1%2026-02-25, Balance as of period end
2024-12-31396.80M+69.4%2026-02-25, Balance as of period end
2023-12-31234.27M+22.6%2025-02-28, Balance as of period end
2022-12-31191.02M+12.2%2024-02-29, Balance as of period end
2021-12-31170.27M+663.1%2023-02-27, Balance as of period end
2020-12-3122.31Mn/a2022-03-23, Balance as of period end